Skip to content

Study Human Digital Support Transitional Care

Contribution of a Digital Tool Combined With Supportive Human Coordination for Transitional Care of Patients in Unscheduled Hospitalisation in Geriatric Short-stay Care

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06354166
Acronym
SUNH-ST
Enrollment
150
Registered
2024-04-09
Start date
2024-04-30
Completion date
2025-03-31
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Brief summary

The purpose of the study is to compare the effectiveness of Divomed in organising complex hospital discharges with a conventional organisation. Effectiveness will be assessed by reducing the length of stay of patients in geriatric short-stay care.

Detailed description

This is an interventional, randomised (ratio 1:1), single-centre, open-label study evaluating Divomed, a digital tool combined with human coordination, to speed up the discharge of people aged over 75 from unscheduled short-stay geriatric hospital admissions to their homes. The study population will be patients aged 75 or over, admitted for short term unscheduled geriatric hospitalisation and eligible for discharge home.

Interventions

PROCEDUREUnscheduled hospital admissions

Unscheduled short-stay geriatric hospitalisations of people aged over 75 to their homes

Sponsors

Divoluci
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

open-label study

Intervention model description

Interventional, randomised (1:1 ratio), single-centre study

Eligibility

Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 75 years ; * Unplanned hospitalisation from emergency, transfers from other inpatient departments or outpatient medicine; * Patient eligible for short-stay geriatric hospitalisation estimated to last at least 10 days; * Patient eligible for a return home; * Patients who have been informed and have signed an informed consent form. If necessary (for cognitive or other reasons), the information must be given to a third party, i.e. the patient's legal representative or trusted person (independent of the investigator and the sponsor), who may be asked to sign or co-sign the informed consent form (depending on the patient's vulnerability).

Exclusion criteria

* Patients scheduled for transfusion, iron infusion or colonoscopy; * Patients in palliative care; * Geographical area other than department 37; * Planned discharge from hospital to a residential establishment for dependent elderly people or to follow-up and rehabilitation care or long-term care units; * Patient or deprived of liberty by judicial or administrative decision ; * Patient participating in or being excluded from another clinical trial; * Patients not covered by a social security scheme.

Design outcomes

Primary

MeasureTime frameDescription
length of stay1 monthThe effectiveness of Divomed in organising complex hospital discharges will be assessed at discharge by comparing lengths of stay in the 2 groups.

Countries

France

Contacts

Primary ContactWassim GANA
w.gana@chu-tours.fr247474747

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026